MiniStudio is a Paris-based AI banner that rolled out in 2024 with just one IP, 'Fuzzlets' which has quietly become a ...
Exelixis has taken a $20 million option to license in an antibody-drug conjugate cancer (ADC) drug from Iconic, with clinical trials expected to start next year. The California biotech had reached an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results